Allschwil, Switzerland – June 26, 2026Idorsia Ltd (SIX: IDIA), a commercial-stage biopharmaceutical company with a portfolio of first- or best-in-class…
Idorsia nominates three Board Directors with outstanding pharmaceutical industry, management and financial expertise for election at the Annual General Meeting…
New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared…